|
1
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pierobon M and Frankenfeld CL: Obesity as
a risk factor for triple-negative breast cancers: A systematic
review and meta-analysis. Breast Cancer Res Treat. 137:307–314.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blows FM, Driver KE, Schmidt MK, Broeks A,
van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO,
Blomqvist C, et al: Subtyping of breast cancer by
immunohistochemistry to investigate a relationship between subtype
and short and long term survival: A collaborative analysis of data
for 10,159 cases from 12 studies. PLoS Med. 7:e10002792010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cui Q, Yu Z, Pan Y, Purisima EO and Wang
E: MicroRNAs preferentially target the genes with high
transcriptional regulation complexity. Biochem Biophys Res Commun.
352:733–738. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim VN and Nam JW: Genomics of microRNA.
Trends Genet. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Feng Y, Qi P, Xu S and Zhou Y:
Mechanism of serum miR-21 in the pathogenesis of familial and
triple negative breast cancer. J Biol Regul Homeost Agents.
30:1041–1045. 2016.PubMed/NCBI
|
|
10
|
Zhang G, Liu Z, Han Y, Wang X and Yang Z:
Overexpression of miR-509 increases apoptosis and inhibits invasion
via suppression of tumor necrosis factor-α in triple-negative
breast cancer Hs578T cells. Oncol Res. 24:233–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mathe A, Wong-Brown M, Morten B, Forbes
JF, Braye SG, Avery-Kiejda KA and Scott RJ: Novel genes associated
with lymph node metastasis in triple negative breast cancer. Sci
Rep. 5:158322015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar :
|
|
13
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
15
|
da W Huang, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sam LT, Mendonca EA, Li J, Blake J,
Friedman C and Lussier YA: PhenoGO: An integrated resource for the
multiscale mining of clinical and biological data. BMC
bioinformatics. 10 Suppl 2:S82009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Labi V and Erlacher M: How cell death
shapes cancer. Cell Death Dis. 6:e16752015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Wang S, Israel HP, Yan SX,
Horowitz DP, Crockford S, Gidea-Addeo D, Chao KS Clifford, Kalinsky
K and Connolly EP: Higher locoregional recurrence rate for
triple-negative breast cancer following neoadjuvant chemotherapy,
surgery and radiotherapy. Springerplus. 4:3862015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim S, Park HS, Kim JY, Ryu J, Park S and
Kim SI: Comparisons of oncologic outcomes between triple-negative
breast cancer (TNBC) and Non-TNBC among patients treated with
breast-conserving therapy. Yonsei Med J. 57:1192–1198. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ,
Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L and Chen YP:
Hepatocellular carcinoma associated microRNA expression signature:
Integrated bioinformatics analysis, experimental validation and
clinical significance. Oncotarget. 6:25093–25108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai M, Chen X, Mo S, Li J, Huang Z, Huang
S, Xu J, He B, Zou Y, Chen J and Dai S: Meta-signature LncRNAs
serve as novel biomarkers for colorectal cancer: Integrated
bioinformatics analysis, experimental validation and diagnostic
evaluation. Sci Rep. 7:465722017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
An N, Shi X, Zhang Y, Lv N, Feng L, Di X,
Han N, Wang G, Cheng S and Zhang K: Discovery of a novel immune
gene signature with profound prognostic value in colorectal cancer:
A model of cooperativity disorientation created in the process from
development to cancer. PloS One. 10:e01371712015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Volinia S and Croce CM: Prognostic
microRNA/mRNA signature from the integrated analysis of patients
with invasive breast cancer. Proc Natl Acad Sci USA. 110:7413–7417.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Peng Y, Jin Z, Huang W, Cheng Y,
Liu Y, Feng X, Yang M, Huang Y, Zhao Z, et al: Integrated miRNA
profiling and bioinformatics analyses reveal potential causative
miRNAs in gastric adenocarcinoma. Oncotarget. 6:32878–32889.
2015.PubMed/NCBI
|
|
25
|
Lovering RC, Camon EB, Blake JA and Diehl
AD: Access to immunology through the gene ontology. Immunology.
125:154–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong H, Li Q, Liu S, Wang F, Xiong Z,
Chen J, Chen H, Yang Y, Tan X, Luo Q, et al: Integrated microRNA
and mRNA transcriptome sequencing reveals the potential roles of
miRNAs in stage I endometrioid endometrial carcinoma. PLoS One.
9:e1101632014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li C, Nong Q, Solanki MK, Liang Q, Xie J,
Liu X and Li Y, Wang W, Yang L and Li Y: Differential expression
profiles and pathways of genes in sugarcane leaf at elongation
stage in response to drought stress. Sci Rep. 6:256982016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma G, Luo Y, Zhu H, Luo Y, Korhonen PK,
Young ND, Gasser RB and Zhou R: MicroRNAs of Toxocara canis and
their predicted functional roles. Parasit Vectors. 9:2292016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lapkina-Gendler L, Rotem I, Pasmanik-Chor
M, Gurwitz D, Sarfstein R, Laron Z and Werner H: Identification of
signaling pathways associated with cancer protection in Laron
syndrome. Endocr Relat Cancer. 23:399–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ,
Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L and Chen YP:
Hepatocellular carcinoma associated microRNA expression signature:
Integrated bioinformatics analysis, experimental validation and
clinical significance. Oncotarget. 6:25093–25108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geraldo MV and Kimura ET: Integrated
analysis of thyroid cancer public datasets reveals role of
post-transcriptional regulation on tumor progression by targeting
of immune system mediators. PLoS One. 10:e01417262015. View Article : Google Scholar : PubMed/NCBI
|
